PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 10, 2026BMJ Open0 citationsOpen Access

Risk factors for skin rash among patients with cancer receiving epidermal growth factor receptor inhibitors: a scoping review protocol

View Full Paper
LZLijuan ZhangYZYazheng ZhaiYWYanru Wang

Key Points

  • This review aims to identify and summarize risk factors associated with skin rash in cancer patients treated with epidermal growth factor receptor inhibitors.
  • Conduct a scoping review using published and publicly available sources
  • Analyze existing literature on risk factors for skin rash
  • Disseminate findings through various academic channels
  • Study does not present results yet as it is a protocol
  • Findings will inform clinical practices upon completion
  • Results may highlight specific demographic or treatment-related risk factors

Abstract

This scoping review will rely exclusively on the collection and analysis of published and/or publicly available sources; therefore, ethical approval is not required. The findings will be disseminated through publication in peer-reviewed journals, presentation at scientific conferences and via digital science communication platforms.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69d893eb6c1944d70ce04d69https://doi.org/10.1136/bmjopen-2025-103333
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rash associated with epidermal growth factor receptor inhibitors: a systematic review and meta-analysis of 194 randomized controlled trials2026
  2. 2Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients2025
  3. 3Best evidence summary for the management of epidermal growth factor receptor inhibitor-induced skin toxicity symptoms in cancer patients2025
  4. 4Cutaneous Adverse Effects of <scp>EGFR</scp> Therapy in Breast Cancer Treatment2025
  5. 5Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review2026 · 1 citations